Trial Details
Not RecruitingBasic Information
| Clinical ID | c5420 |
|---|---|
| Identifier | ACTRN12624000239561 |
| Trial Title | A Single Ascending dose to assess the safety, tolerability and pharmacokinetics of TP-317 under fasted conditions in adult healthy volunteers. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | Yes |
|---|---|
| Conditions | Inflammatory bowel disease; Inflammatory bowel disease;Oral and Gastrointestinal - Inflammatory bowel disease |
| Interventions | The study consists of 3 planned dose cohorts where each cohort will enrol a total of 8 participants of which 6 randomised to TP-317 treatment arm and 2 randomised to the placebo treatment arm. A total of 24 participants will be enrolled for this study.<br |
Participant Information
| Sponsor | Thetis Pharmaceuticals LLC |
|---|---|
| City | NULL |
| Country/Region | Australia |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |